OMERS Administration Corp’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,587
Closed -$260K 1159
2025
Q4
$260K Hold
1,587
﹤0.01% 846
2025
Q3
$212K Buy
+1,587
New +$193K ﹤0.01% 971
2025
Q2
Sell
-1,587
Closed -$202K 1061
2025
Q1
$202K Sell
1,587
-257
-14% -$39.6K ﹤0.01% 935
2024
Q4
$265K Hold
1,844
﹤0.01% 839
2024
Q3
$274K Hold
1,844
﹤0.01% 758
2024
Q2
$232K Buy
+1,844
New +$289K ﹤0.01% 857
2017
Q4
Sell
-12,500
Closed -$479K 463
2017
Q3
$479K Buy
12,500
+6,100
+95% +$256K 0.01% 347
2017
Q2
$265K Buy
+6,400
New +$243K ﹤0.01% 430

Other funds holding RGEN

OMERS Administration Corp's RGEN Position: Q1 2026 in Review

OMERS Administration Corp sold out of Repligen (RGEN) in Q1 2026, closing a stake of 1,587 shares — an estimated $260K sold.

OMERS Administration Corp first reported a position in RGEN in Q2 2017 and held it in 8 quarters. The position peaked at $479K in Q3 2017. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • OMERS Administration Corp reported no remaining Repligen position as of Q1 2026 after selling out during the quarter.
  • OMERS Administration Corp sold 1,587 Repligen shares in Q1 2026, an estimated $260K.
  • OMERS Administration Corp first reported a position in Repligen in Q2 2017 and held it in 8 quarters.
  • OMERS Administration Corp's Repligen position peaked at $479K in Q3 2017.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on OMERS Administration Corp's 13F filing for Q1 2026, filed 15 May 2026.